-->
Dental 3D printing devices market was valued at US$ 10.50 billion in 2024 and is projected to hit the market valuation of US$ 50.10 billion by 2033 at a CAGR of 18.96% during the forecast period 2025–2033.
Glaucoma surgical devices market was valued at US$ 742 million in 2024 and is projected to surpass the valuation of US$ 1,546 million by 2033 at a CAGR of 8.5% during the forecast period 2025–2033.
Asia Pacific organoids and spheroids market was valued at US$ 246.66 million in 2024 and is projected to hit the market valuation of US$ 1,444.49 million by 2033 at a CAGR of 21.70% during the forecast period 2025–2033.
Japan wound care market was valued at US$ 1,562.84 million in 2024 and is projected to hit the market valuation of US$ 2,965.99 million by 2033 at a CAGR of 7.59% during the forecast period 2025–2033.
Japan pressure ulcer care dressing market was valued at US$ 129.68 million in 2023 and is projected to hit the market valuation of US$ 226.75 million by 2032 at a CAGR of 6.52% during the forecast period 2024–2032.
Organ on a Chip Market was valued at US$ 157.06 million in 2024 and is projected to hit the market valuation of US$ 2,238.28 million by 2033 at a CAGR of 34.34% during the forecast period 2025–2033.
The U.S. sterility testing market was valued at US$ 448.36 million in 2023 and is projected to hit the market valuation of US$ 1,198.13 million by 2032 at a CAGR of 11.54% during the forecast period 2024–2032.
Sterility testing market was valued at US$ 1,118.59 million in 2023 and is projected to hit the market valuation of US$ 2,945.74 million by 2032 at a CAGR of 11.36% during the forecast period 2024–2032.
Japan knee hyaluronic acid injections market was valued at US$ 160.63 million in 2023 and is projected to hit the market valuation of US$ 260.41 million by 2032 at a CAGR of 5.8% during the forecast period 2024–2032.